SWS Partners lessened its position in shares of Edwards Lifesciences Co. (NYSE:EW – Get Rating) by 14.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,573 shares of the medical research company’s stock after selling 2,202 shares during the period. SWS […]